Omega 3-PUFA Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Omega-3 PUFA Market Report is Segmented by Product Type (Plant, Marine), Type (Docosahexanoic Acid, Eicosapentanoic Acid and More ), Application (Food and Beverage, Dietary Supplements, Pharmaceutical, Animal Feed and Others), and Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Omega 3-PUFA Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Omega 3-PUFA Market with other markets in Food & Beverage Industry

Omega 3-PUFA Market Analysis by Mordor Intelligence

The omega-3 PUFA market was valued at USD 2.76 billion in 2025 and is forecast to reach USD 3.88 billion by 2030, advancing at a steady 7.05% CAGR. This growth is driven by increasing consumer awareness of the health benefits associated with omega-3 fatty acids, including their role in reducing inflammation and supporting overall well-being. Heightened concerns over cardiovascular and cognitive health, backed by expanding clinical evidence and favorable regulations, solidify consumer trust in omega-3 fortified products. While marine oils continue to dominate, there's a swift rise in plant-based alternatives, driven by sustainability considerations. Key economies, particularly China and the European Union, are modernizing regulations, hastening product development cycles and raising quality standards. Additionally, advancements in extraction technologies and the development of innovative delivery formats, such as gummies and soft gels, are further fueling market expansion.

Key Report Takeaways

  • By product type, marine-derived ingredients led with 75.11% revenue share in 2024; plant-based sources are poised to expand at an 8.48% CAGR to 2030.
  • By type, DHA accounted for 42.47% of the omega-3 PUFA market share in 2024, while the EPA segment is projected to grow at 8.08% CAGR through 2030.
  • By application, food and beverages contributed 36.34% of the omega-3 PUFA market size in 2024 and pharmaceuticals are advancing at a 7.87% CAGR.
  • By geography, North America captured 31.22% of the omega-3 PUFA market in 2024; Asia-Pacific is registering the fastest pace at 9.04% CAGR.

Segment Analysis

By Product Type: Marine Dominance Faces Plant-Based Disruption

Marine-derived oils held a dominant 75.11% share of the omega-3 PUFA market in 2024. This dominance is attributed to their well-established supply chains, competitive cost structures, and high concentrations of EPA and DHA, which are critical for various health benefits. The market size for marine oils is expected to grow in line with the increasing global demand for omega-3 PUFAs. However, their relative market share is anticipated to decline as plant-based alternatives continue to gain traction, driven by shifting consumer preferences and sustainability concerns.

Plant-based omega-3 solutions are experiencing rapid growth, with a robust CAGR of 8.48%. This growth is fueled by the rising adoption of vegan lifestyles and increasing awareness of environmental sustainability. A notable development in this segment is DSM-Firmenich's introduction of life’sOMEGA, the first plant-based ingredient to deliver both EPA and DHA, effectively addressing a longstanding nutritional gap in the market. The innovation and expanding availability of plant-based alternatives are expected to significantly influence the competitive dynamics of the omega-3 PUFA market in the coming years.

Omega -3 PUFA Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Type: DHA Leadership Challenged by EPA’s Clinical Momentum

In 2024, DHA held a significant 42.47% share of the omega-3 PUFA market. This dominance is primarily driven by global mandates requiring the inclusion of DHA in infant formulas, which underscores its critical role in early childhood development. Decades of research have consistently highlighted DHA's importance in supporting cognitive health, particularly in brain and eye development. The increasing awareness of these benefits has led to a surge in demand for DHA-enriched products, not only in infant nutrition but also in dietary supplements and functional foods targeted at adults and the aging population.

EPA, on the other hand, is emerging as a key growth driver within the omega-3 PUFA market, registering an impressive CAGR of 8.08%. The rising prevalence of cardiovascular diseases globally has amplified the demand for EPA, as numerous randomized clinical trials have demonstrated its significant cardiovascular benefits, including reducing inflammation and improving heart health. EPA-focused products are increasingly gaining traction among health-conscious consumers, particularly those seeking targeted solutions for heart health and overall wellness. Additionally, the growing adoption of EPA in pharmaceutical formulations and its expanding applications in functional foods and beverages are expected to further drive its market growth. 

By Application: Food and Beverages Lead While Pharmaceuticals Accelerate

In 2024, food and beverage sales accounted for 36.34% of total sales, driven by manufacturers reformulating cereals, dairy products, and ready meals in response to the FDA's updated "healthy" definition. The reformulation efforts aim to align with consumer demand for healthier options, which has been further influenced by regulatory changes. This trend highlights the growing emphasis on nutritional value and transparency in the food and beverage market, positioning it as a significant contributor to the Omega-3 PUFA market's growth. Additionally, the incorporation of Omega-3 PUFA into functional foods and beverages, such as fortified juices, milk, and snacks, is gaining traction. This is driven by increasing consumer awareness of Omega-3's health benefits, including improved heart health, brain function, and overall wellness. 

Meanwhile, the pharmaceutical sector is outpacing with a robust 7.87% CAGR. The sector's growth is fueled by the increasing adoption of Omega-3 PUFA in the development of drugs targeting cardiovascular health, mental well-being, and inflammatory conditions. The rising prevalence of chronic diseases, such as heart disease and arthritis, coupled with growing awareness of Omega-3's therapeutic benefits, is driving pharmaceutical manufacturers to integrate these fatty acids into their product portfolios. Furthermore, the pharmaceutical market is witnessing advancements in Omega-3 formulations, including prescription-grade products and innovative delivery systems, such as soft gels and capsules, to enhance bioavailability and patient compliance. 

Omega-3 PUFA Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Geography Analysis

In 2024, North America holds a dominant 31.22% share of the market, bolstered by its advanced regulatory frameworks, a well-entrenched culture of supplements, and a robust clinical research infrastructure that underscores the health benefits of omega-3s. The region enjoys a favorable market landscape, thanks to the FDA's progressive approach towards qualified health claims and its revised definition of "healthy" labeling, which now encompasses omega-3-rich foods. These regulatory advancements not only encourage product innovation but also enhance consumer confidence and adoption, creating a thriving environment for omega-3 products.

Meanwhile, the Asia-Pacific region is on a rapid ascent, projected to grow at a 9.04% CAGR through 2030. This surge is fueled by an uptick in health consciousness, a move towards regulatory harmonization, and a burgeoning middle class in pivotal markets. China's recent move to include DHA in its Health Food Raw Materials Directory, stipulating a daily intake limit of 200-1000mg for adults, underscores a maturing regulatory landscape that's poised to bolster market growth. Additionally, Japan and South Korea continue to lead with the highest global omega-3 index scores, reflecting their strong consumer awareness and established consumption patterns. In contrast, Chinese consumers are increasingly showing interest in fish oils, signaling a growing market potential despite their historically lower baseline consumption levels.

Europe is witnessing consistent growth, driven by initiatives centered on sustainability and the approval of novel foods. The EFSA's recent guidance updates have further smoothed the path for innovative omega-3 sources to enter the market. These measures align with the region's focus on environmental responsibility and consumer safety, ensuring steady market expansion. Meanwhile, South America and the Middle East and Africa are emerging as promising frontiers. In Brazil, ANVISA has rolled out updates to food supplement regulations, aimed at improving product standards and market accessibility. Similarly, Saudi Arabia is advancing its nutritional labeling standards, which could significantly enhance omega-3 market access and consumer awareness in the region. Both regions present untapped opportunities for growth, driven by evolving regulatory landscapes and increasing consumer interest in health and wellness products.

Omega-3 PUFA Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The omega-3 PUFA market is moderately fragmented, is characterized by a balanced dynamic created by established marine oil producers and emerging algae-based innovators. The market has witnessed significant strategic consolidations, which are reshaping its structure. For instance, Louis Dreyfus Company's acquisition of BASF's food and health ingredients business and KD Pharma Group's purchase of DSM-Firmenich's marine lipids operations, including the MEG-3 brand and production facilities in Peru and Canada, are notable examples. These acquisitions reflect a growing trend of vertical integration, enabling companies to secure control over their supply chains while expanding their geographic presence and technological capabilities.

Innovation plays a pivotal role in intensifying competition within the market. Companies are increasingly focusing on bioavailability enhancement technologies to improve the efficacy of omega-3 PUFA products. For example, advancements in microencapsulation techniques and emulsification processes are being adopted to enhance the absorption of omega-3 fatty acids in the human body. Additionally, sustainable sourcing initiatives are gaining traction, with companies exploring algae-based omega-3 production as an alternative to traditional fish oil. This shift not only addresses environmental concerns but also ensures a steady supply of raw materials, reducing dependency on marine resources.

Furthermore, the market is witnessing collaborations and partnerships aimed at driving innovation and expanding product portfolios. For instance, partnerships between biotechnology firms and omega-3 manufacturers are fostering the development of novel products tailored to specific consumer needs, such as vegan omega-3 supplements. The competitive landscape is also influenced by regional players who are leveraging local resources and expertise to cater to domestic demand. These dynamics collectively contribute to a vibrant and evolving market environment, where companies are striving to differentiate themselves through innovation, sustainability, and strategic growth initiatives.

Omega 3-PUFA Industry Leaders

  1. Cargill, Incorporated

  2. BASF SE

  3. Archer Daniels Midland Company

  4. DSM-Firmenich AG

  5. Corbion N.V.

  6. *Disclaimer: Major Players sorted in no particular order
Omega-3 PUFA Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • January 2025: Epax announced USD 10 million investment to boost omega-11 production capabilities, signaling expansion beyond traditional EPA/DHA focus into emerging omega fatty acid variants. Omega-11 has been studied for its ability to convert the plant-based omega-3 alpha-lipoic acid (ALA) into eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in liver cells.
  • December 2024: Louis Dreyfus Company completed acquisition of BASF's food and health performance ingredients business, expanding capabilities in omega-3 ingredient manufacturing and distribution across global markets.
  • October 2024: DSM-Firmenich launched life's DHA B54-0100, a high-potency algae-derived omega-3 ingredient providing 545mg DHA and 80mg EPA per gram, enabling smaller capsule formulations and eliminating fishy odors for gummy applications.
  • October 2024: CoreFX has launched a new range of omega powders, branded as CoreNhanced, featuring EPA, DHA, ALA, and SDA oils sourced from fish, algae, flax, and Ahiflower. These omega powders are designed to provide a versatile and convenient solution for incorporating essential fatty acids into various applications, catering to the growing demand for functional and nutritional ingredients in the food and beverage industry.

Table of Contents for Omega 3-PUFA Industry Report

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET LANDSCAPE

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growth of Omega-3 Enriched Food and Beverage Products to Support Cardiovascular Health
    • 4.2.2 Rising Consumer shift Towards Preventive Heathcare
    • 4.2.3 High Adoption in Dietary Supplements and Functional Nutrition
    • 4.2.4 Surge in Cognitive Health Supplemnt Among Aging Population
    • 4.2.5 Increased Application in Animal and Pet Feed
    • 4.2.6 Widespread Adoption in Functional Bakery and Dairy Products
  • 4.3 Market Restraints
    • 4.3.1 Unpleasant Odor and Taste in marine Derived Omega-3s
    • 4.3.2 Stringent Regulatory Approvals
    • 4.3.3 Concern Regarding Overfishing and Marine Ecosystem Damage
    • 4.3.4 Complexity in Bioavailability and Absorption Among Different Types
  • 4.4 Supply Chain Analysis
  • 4.5 Regulatory Outlook
  • 4.6 Porter's Five Forces
    • 4.6.1 Threat of New Entrants
    • 4.6.2 Bargaining Power of Buyers/Consumers
    • 4.6.3 Bargaining Power of Suppliers
    • 4.6.4 Threat of Substitute Products
    • 4.6.5 Intensity of Competitive Rivalry

5. MARKET SIZE AND GROWTH FORECASTS (VALUE)

  • 5.1 By Product Type
    • 5.1.1 Plant
    • 5.1.2 Marine
  • 5.2 By Type
    • 5.2.1 Docosahexanoic acid (DHA)
    • 5.2.2 Eicosapentanoic acid (EPA)
    • 5.2.3 Alpha-Linolenic Acid (ALA)
    • 5.2.4 Others
  • 5.3 By Application
    • 5.3.1 Food and Beverages
    • 5.3.2 Dietary Supplements
    • 5.3.3 Pharmaceutical
    • 5.3.4 Animal Feed
    • 5.3.5 Others
  • 5.4 By Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.1.4 Rest of North America
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 Italy
    • 5.4.2.4 France
    • 5.4.2.5 Spain
    • 5.4.2.6 Poland
    • 5.4.2.7 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 India
    • 5.4.3.3 Japan
    • 5.4.3.4 Australia
    • 5.4.3.5 Rest of Asia-Pacific
    • 5.4.4 South America
    • 5.4.4.1 Brazil
    • 5.4.4.2 Argentina
    • 5.4.4.3 Rest of South America
    • 5.4.5 Middle East and Africa
    • 5.4.5.1 South Africa
    • 5.4.5.2 Saudi Arabia
    • 5.4.5.3 United Arab Emirates
    • 5.4.5.4 Rest of Middle East and Africa

6. COMPETITIVE LANDSCAPE

  • 6.1 Market Concentration
  • 6.2 Strategic Moves
  • 6.3 Market Ranking Analysis
  • 6.4 Company Profiles (includes Global-level Overview, Market-level Overview, Core Segments, Financials (if available), Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
    • 6.4.1 BASF SE
    • 6.4.2 DSM-Firmenich AG
    • 6.4.3 Cargill, Incorporated
    • 6.4.4 Archer Daniels Midland Company
    • 6.4.5 Corbion N.V.
    • 6.4.6 Croda International Plc
    • 6.4.7 Aker BioMarine AS
    • 6.4.8 Epax Norway AS
    • 6.4.9 KD Pharma Group
    • 6.4.10 Omega Protein Corporation
    • 6.4.11 Solutex GC
    • 6.4.12 Neptune Wellness Solutions Inc.
    • 6.4.13 Algarithm Ingredients Inc.
    • 6.4.14 Stepan Company
    • 6.4.15 Novotech Nutraceuticals
    • 6.4.16 Clover Corporation Limited
    • 6.4.17 Qualitas Health
    • 6.4.18 Nordic Naturals, Inc.
    • 6.4.19 Lonza Group
    • 6.4.20 Arista Industries, Inc.

7. MARKET OPPORTUNITIES AND FUTURE OUTLOOK

You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Omega 3-PUFA Market Report Scope

The global omega-3 PUFA market has been segmented by source into plant and marine sources; and by type into Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA), Alpha-Linolenic Acid (ALA), and others. By concentration, the market is segmented into high concentration, medium concentration, and low concentration; and by application into food and beverage, dietary supplements, pharmaceuticals, and animal feed. The market is also segmented by geography into North America, Europe, Asia-Pacific, South America, and the Middle East & Africa. The report offers market size and forecasts for the organic food and beverages market in value (USD million) for all the above segments.

By Product Type Plant
Marine
By Type Docosahexanoic acid (DHA)
Eicosapentanoic acid (EPA)
Alpha-Linolenic Acid (ALA)
Others
By Application Food and Beverages
Dietary Supplements
Pharmaceutical
Animal Feed
Others
By Geography North America United States
Canada
Mexico
Rest of North America
Europe Germany
United Kingdom
Italy
France
Spain
Poland
Rest of Europe
Asia-Pacific China
India
Japan
Australia
Rest of Asia-Pacific
South America Brazil
Argentina
Rest of South America
Middle East and Africa South Africa
Saudi Arabia
United Arab Emirates
Rest of Middle East and Africa
By Product Type
Plant
Marine
By Type
Docosahexanoic acid (DHA)
Eicosapentanoic acid (EPA)
Alpha-Linolenic Acid (ALA)
Others
By Application
Food and Beverages
Dietary Supplements
Pharmaceutical
Animal Feed
Others
By Geography
North America United States
Canada
Mexico
Rest of North America
Europe Germany
United Kingdom
Italy
France
Spain
Poland
Rest of Europe
Asia-Pacific China
India
Japan
Australia
Rest of Asia-Pacific
South America Brazil
Argentina
Rest of South America
Middle East and Africa South Africa
Saudi Arabia
United Arab Emirates
Rest of Middle East and Africa
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the projected size of the omega-3 PUFA market by 2030?

The omega-3 PUFA market is expected to reach USD 3.88 billion by 2030, supported by a 7.05% CAGR.

Which product type currently dominates the omega-3 PUFA market?

Marine-derived oils lead with 75.11% share due to mature supply chains and high EPA/DHA concentrations.

Why are plant-based omega-3 sources growing faster than marine oils?

Plant sources offer sustainability advantages, meet vegan preferences, and alleviate overfishing concerns, resulting in an 8.48% CAGR.

Which region shows the highest growth rate for omega-3 products?

Asia-Pacific is expanding the fastest at 9.04% CAGR, driven by rising health awareness and supportive regulations.

What are the main restraints facing the omega-3 PUFA market?

Sensory issues with marine oils, stringent regulatory approvals, and ecosystem sustainability concerns are the key hurdles.

Page last updated on: July 3, 2025

Omega 3-PUFA Market Report Snapshots